Potential diagnostic consequences of applying non‐invasive prenatal testing: population‐based study from a country with existing first‐trimester screening

…, M Østergaard, S Pouplier, AC Shalmi… - … in Obstetrics & …, 2014 - Wiley Online Library
Objectives Targeted non‐invasive prenatal testing ( NIPT ) tests for trisomies 21, 18 and 13
and sex chromosome aneuploidies and could be an alternative to traditional karyotyping. …

Reduction of the disintegrin and metalloprotease ADAM12 in preeclampsia

…, KR Wøjdemann, K Sundberg, AC Shalmi… - Obstetrics & …, 2005 - journals.lww.com
Objectives: The secreted form of ADAM12 is a metalloprotease that may be involved in
placental and fetal growth. We examined whether the concentration of ADAM12 in first-trimester …

Prenatal detection of congenital heart disease in a low risk population undergoing first and second trimester screening

…, FS Jørgensen, T Larsen, AC Shalmi… - Prenatal …, 2015 - Wiley Online Library
Objectives The prenatal detection rate of congenital heart disease (CHD) is low compared
with other fetal malformations. Our aim was to evaluate the prenatal detection of CHD in …

Antenatal magnesium sulphate for the prevention of cerebral palsy in infants born preterm: a double‐blind, randomised, placebo‐controlled, multi‐centre trial

…, A Aabakke, L Helleland, AC Shalmi… - … Journal of Obstetrics …, 2020 - Wiley Online Library
Objective To study the effect of antenatal magnesium sulphate (MgSO 4 ) on cerebral palsy (CP)
in a manner that also provides adequate power for a linked trial sequential analysis. …

Placental protein-13 (PP13) in combination with PAPP-A and free leptin index (fLI) in first trimester maternal serum screening for severe and early preeclampsia

…, S Placing, KR Wøjdemann, AC Shalmi… - Clinical Chemistry and …, 2017 - degruyter.com
Background: Placental protein-13 (PP13) is involved in placental invasion and has been
suggested as a maternal serum marker of preeclampsia (PE) development. However, the …

Gender impact on first trimester markers in Down syndrome screening

SO Larsen, KR Wøjdemann, AC Shalmi… - … in Affiliation With the …, 2002 - Wiley Online Library
The influence of fetal gender on the level in the first trimester of the serological markers
alpha‐fetoprotein (AFP), pregnancy‐associated plasma protein‐A (PAPP‐A) and free beta …

Free leptin index and PAPP‐A: a first trimester maternal serum screening test for pre‐eclampsia

…, K Wøjdemann, AL Carlsen, AC Shalmi… - … in Affiliation With the …, 2010 - Wiley Online Library
Background Prophylaxis with low‐dose aspirin may reduce the risk of pre‐eclampsia (PE) if
introduced in first trimester. The performance of first trimester maternal serum screening for …

Increased nuchal translucency, normal karyotype and infant development

…, H Zingenberg, A Nikkilä, AC Shalmi… - … in obstetrics & …, 2012 - Wiley Online Library
Objective To investigate whether chromosomally normal fetuses with a nuchal translucency (NT)
≥ 99 th percentile (3.5 mm) in the first trimester have an increased risk of delayed …

Maternal serum resistin is reduced in first trimester preeclampsia pregnancies and is a marker of clinical severity

…, JM Jørgensen, AC Gjerris, AC Shalmi… - Hypertension in …, 2015 - Taylor & Francis
Objective: To examine whether resistin levels in first trimester maternal serum are associated
with insulin resistance or preeclampsia (PE). Methods: A case-control study of maternal …

Nuchal translucency measurements are highly correlated in both mono‐and dichorionic twin pairs

KR Wøjdemann, SO Larsen, AC Shalmi… - … in Affiliation With the …, 2006 - Wiley Online Library
Objectives To establish the distribution of serological and ultrasound first‐trimester Down
syndrome markers in twins and identify correlations of significance for risk calculation. Methods …